Arteris, Inc. (NASDAQ:AIP – Get Free Report) CEO K Charles Janac sold 14,180 shares of the stock in a transaction on Tuesday, December 17th. The stock was sold at an average price of $10.01, for a total value of $141,941.80. Following the completion of the transaction, the chief executive officer now owns 10,207,746 shares of the company’s stock, valued at $102,179,537.46. The trade was a 0.14 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.
K Charles Janac also recently made the following trade(s):
- On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
- On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The shares were sold at an average price of $8.58, for a total transaction of $10,656.36.
- On Wednesday, October 2nd, K Charles Janac sold 5,520 shares of Arteris stock. The stock was sold at an average price of $7.18, for a total value of $39,633.60.
Arteris Price Performance
NASDAQ:AIP traded down $0.39 during trading hours on Thursday, reaching $8.95. 183,679 shares of the company traded hands, compared to its average volume of 167,448. Arteris, Inc. has a 1-year low of $4.83 and a 1-year high of $10.60. The stock has a market cap of $359.58 million, a P/E ratio of -9.32 and a beta of 1.25. The firm’s 50-day moving average is $8.15 and its 200-day moving average is $7.86. The company has a debt-to-equity ratio of 0.30, a current ratio of 1.16 and a quick ratio of 1.16.
Analysts Set New Price Targets
View Our Latest Analysis on Arteris
Institutional Inflows and Outflows
Several institutional investors have recently added to or reduced their stakes in AIP. US Bancorp DE purchased a new stake in shares of Arteris during the third quarter worth about $34,000. The Manufacturers Life Insurance Company acquired a new stake in Arteris during the second quarter worth approximately $86,000. Algert Global LLC purchased a new stake in Arteris in the 2nd quarter worth approximately $115,000. MetLife Investment Management LLC increased its stake in Arteris by 129.1% in the third quarter. MetLife Investment Management LLC now owns 16,951 shares of the company’s stock valued at $131,000 after purchasing an additional 9,551 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd purchased a new position in Arteris during the third quarter worth about $226,000. Institutional investors and hedge funds own 64.36% of the company’s stock.
Arteris Company Profile
Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.
Further Reading
- Five stocks we like better than Arteris
- ETF Screener: Uses and Step-by-Step Guide
- Micron Stock Under $100: Seize the AI-Driven Upside
- Market Cap Calculator: How to Calculate Market Cap
- AI’s Next Big Winners: 3 Small-Cap Stocks to Watch in 2025
- Best Stocks Under $10.00
- SolarEdge Stock Climbs Back: Goldman Sachs Sees 40% Upside
Receive News & Ratings for Arteris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arteris and related companies with MarketBeat.com's FREE daily email newsletter.